Regenerative Medical Technology (RMTG) Operating Income (2018 - 2026)
Regenerative Medical Technology (RMTG) posted quarterly Operating Income of $229783.0 for Q1 2026, up 70.26% year-over-year from $134960.0 in Q1 2025, and up 175.03% quarter-over-quarter from -$306274.0 in Q4 2025.
Regenerative Medical Technology (RMTG) Operating Income (2018 - 2026) Analysis & Trends
Regenerative Medical Technology's Operating Income history runs 9 years deep, the most recent figure standing at $229783.0 for Q1 2026.
- In Q1 2026, Operating Income rose 70.26% year-over-year to $229783.0; the TTM figure through Mar 2026 stood at -$772338.0 (down 340.42% YoY), while the FY2025 annual figure was -$867162.0, down 1168.18% from the prior year.
- Operating Income for Q1 2026 stood at $229783.0, up from -$306274.0 in the prior quarter.
- The five-year high for Operating Income was $380618.0 in Q4 2024, with the low at -$2.5 million in Q4 2022.
- The 5-year median for Operating Income is -$161659.0 (2022), against an average of -$282248.9.
- The sharpest annual moves came in 2024 and 2025: Operating Income soared 381.71% in 2024, then slumped 2368.73% in 2025.
- Regenerative Medical Technology's Operating Income stood at -$2.5 million in 2022, then soared by 94.5% to -$135111.0 in 2023, then jumped by 381.71% to $380618.0 in 2024, then tumbled by 180.47% to -$306274.0 in 2025, then surged by 175.03% to $229783.0 in 2026.
- Business Quant data shows RMTG's Operating Income at $229783.0 in Q1 2026, -$306274.0 in Q4 2025, and -$445761.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Op. Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 1.25 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 1.29 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 493.00 Mn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | -815.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 325.05 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 231.44 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | -375.75 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | -1.55 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 133.12 Mn |
| 10 | Regenerative Medical Technology | 1.58 Mn | 515,228.12 | 1.77 Mn | 229,783.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 229,783.00 |
| Dec 31, 2025 | -306,274.00 |
| Sep 30, 2025 | -445,761.00 |
| Jun 30, 2025 | -250,086.00 |
| Mar 31, 2025 | 134,960.00 |
| Dec 31, 2024 | 380,618.00 |
| Sep 30, 2024 | 19,648.00 |
| Jun 30, 2024 | -213,981.00 |
| Mar 31, 2024 | -105,105.00 |
| Dec 31, 2023 | -135,111.00 |
| Sep 30, 2023 | -75,063.00 |
| Jun 30, 2023 | -430,841.00 |
| Mar 31, 2023 | -74,211.00 |
| Dec 31, 2022 | -2.46 Mn |
| Sep 30, 2022 | -161,659.00 |
| Jun 30, 2022 | -365,622.00 |
| Mar 31, 2022 | -542,390.00 |
| Dec 31, 2021 | -496,565.00 |
| Sep 30, 2021 | -9.02 Mn |
| Jun 30, 2021 | -254,511.00 |